Table 1: Characteristics of PAF patients by berberine and amiodarone groups.

CategoryBerberine
Amiodarone
Significance

Age (year)NS
Male28 (62.2%)27 (62.8%)NS
Duration (hour)4846NS
Frequency (time/month)5.56.3NS
History (month)9.59.3NS
Smoking status
Never smoking22 (48.9%)20 (46.6%)NS
Smoking < 5 year8 (17.8%)9 (21%)NS
Smoking ≥ 5 year15 (33.4%)14 (32.6%)NS
K (mmol/L)4.14.2NS
Mg (mmol/L)1.01.1NS
TSH (u/ml)1.51.4NS
ALT (u/ml)1718NS
AST (u/ml)1618
CR (µmol/L)7674NS
PT (sec)12.212.8NS
INR0.920.95NS
NYHA classification
ΙΙ3129NS
ΙΙΙ1414NS
Concomitant CVD
CAD3936NS
DCM67NS
HTN4140NS
HF23NS
Concomitant medication
Aspirin2120NS
Nitrates2221NS
ACE inhibitors4141NS
Statins2120NS

Notes. ACE, angiotensin-converting enzyme; ALT, alanine transaminase; AST, aspartate transaminase; CAD, coronary artery disease; CR, creatinine; CVD, cardiovascular disease; DCM, dilated cardiomyopathy; HF, heart failure; HTN, hypertension; INR, international normalized ratio; K, potassium; Mg, magnesium; NS, nonsignificant between groups; NYHA, New York Heart Association; PT, prothrombin time; TSH, thyroid-stimulating hormone.